Stay updated on AB680 Safety in Gastrointestinal Malignancies Clinical Trial
Sign up to get notified when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.

Latest updates to the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page
- Check5 days agoChange DetectedThe study record for the completed Phase 1 ARC-8 trial is available, with details on its pancreatic cancer treatment arms, eligibility criteria, study locations, and measured outcomes. It also includes publication and data-sharing information.SummaryDifference82%

- Check12 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA banner about NIH website terminology changes was added, and the site revision changed from v3.7.1 to v3.7.2. The study page still displays a 403 Forbidden error.SummaryDifference1%

- Check40 days agoChange DetectedThe footer’s ClinicalTrials.gov revision indicator changes from v3.7.0 to v3.7.1, while the page continues to display a 403 error instead of the study record.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record details, presenting an access-denied screen with a minimal header and a Home link.SummaryDifference22%

- Check61 days agoChange DetectedThe study record's status was updated to Completed with an Actual primary completion date of 2026-07-21, replacing the previous Active, not recruiting/Estimated status. The record also shows a new Revision: v3.7.0 and update dates, reflecting the latest changes to the study record.SummaryDifference0.4%

Stay in the know with updates to AB680 Safety in Gastrointestinal Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.